Zepbound 2.5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F0LR4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $22,835
Award facts
- Contract value 100% obligated
- $22,834.86 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $22,834.86 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Zepbound 2.5 mg/0.5 mL pen injectors on December 22, 2025, with completion targeted for December 23, 2025. This competitively awarded, non-set-aside contract will be performed at the awardee's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive pharmaceutical support vehicle running through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, supplies a wide range of medications and medical commodities to military and veteran healthcare systems through multiple contract vehicles with the Defense Logistics Agency. This specific delivery order for Zepbound, a GLP-1 receptor agonist used for weight management, reflects the company's role in supporting the Defense Health Agency's pharmaceutical procurement needs. The award demonstrates AmerisourceBergen's continued capability to fulfill federal medical supply requirements through open competition, consistent with its extensive portfolio of delivery orders covering therapeutic domains including endocrinology, neurology, and general medical supplies.
Quick answers
Who was awarded contract SPE2DR26F0LR4?
SPE2DR26F0LR4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 22, 2025.
How much is contract SPE2DR26F0LR4 worth?
The government has obligated $22,835 on SPE2DR26F0LR4.
Is contract SPE2DR26F0LR4 an order under another contract?
Yes. SPE2DR26F0LR4 is a delivery order under SPE2DR25D3007, an indefinite delivery contract.
Was contract SPE2DR26F0LR4 competed?
The extent of competition for SPE2DR26F0LR4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award